Kygevvi (doxecitine and doxribtimine) for thymidine kinase 2 deficiency: a turning point for an ultra-rare mitochondrial disorder
2026Journal of Rare DiseasesJournalOpen access
10.1007/s44162-026-00209-yFull text0 citations
2026Journal of Rare DiseasesJournalOpen access
10.1007/s44162-026-00209-yFull text0 citations
14 authors across 6 institutions in 2 countries.
Assignment is probabilistic — a work belongs to several fields in proportions.
Several sources describing one work is the point — it means the record rests on more than one authority.
2026 · Journal of Rare Diseases · 0 citations
https://openalex.org/W7163884412